Newron Pharmaceuticals SpA Alternatives & Competitors
12 companies similar to Newron Pharmaceuticals SpA — The Specialist in CNS Drug Development
Companies similar to Newron Pharmaceuticals SpA
Chase Pharmaceuticals
Pioneering advancements in neuropsychiatric treatment for a brighter future
PsychoGenics
Discover Your Next Breakthrough
Paramus, United States
Acadia Pharmaceuticals
Acadia is trailblazing breakthroughs in neuroscience to elevate life.
San Diego, United States
Addex Therapeutics
Allosteric modulators for Human Health
Plan-les-ouates, Switzerl...
Track all Newron Pharmaceuticals SpA competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Asceneuron SA
Targeting the root cause of neurodegeneration
Lausanne, Switzerland
Karuna Therapeutics
Pushing the boundaries of neuroscience to transform the treatment of mental illness.
Boston, United States
Lyndra Therapeutics
What if we stopped trying to change the patient and changed the pill instead?
Watertown, United States
Santaris Pharma
Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse diseas...
Atlantic Healthcare
Innovating therapeutic solutions for gastrointestinal diseases and unmet patient needs wor...
Cavion
Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...
Creative BioTherapeutics LLC
An emerging biotech discovering & developing novel therapies for cancer and viruses where...
Gurnee, United States
Dynacure
Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 prog...
Illkirch-graffenstaden, F...
About Newron Pharmaceuticals SpA
Newron Pharmaceuticals is a biopharmaceutical company headquartered in Italy, with a subsidiary in the USA. The company, founded in 1999, specializes in developing novel therapies for diseases of the central nervous system (CNS) and pain. With a balanced and robust pipeline of drug candidates at different clinical stag...
Biopharmaceutical, CNS Drug Development, Parkinson's Disease Treatment, Neurological Disorders, Rare Diseases, Pharmaceutical Commercialization, Clinical Development, Schizophrenia Treatment, Drug Candidates, Innovative Therapies, SIX Swiss Exchange, European Pharmaceutical Companies, US Pharmaceutical Market, Neurological Drug Research, Italian Biopharmaceutical Companies
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Newron Pharmaceuticals SpA and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Newron Pharmaceuticals SpA on 14 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 29 May 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
